longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

VRNS

VRNS
----

LongbridgeAI

These Analysts Revise Their Forecasts On Varonis Following Q2 Earnings

benzinga_article
Jul 29, 2026 at 02:42 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Varonis Systems (VRNS) beat Q2 earnings and raised FY2026 guidance, yet shares fell 8.2%. Following the announcement, analysts revised price targets: Needham raised to $50, Baird to $45, TD Cowen to $53, while Barclays lowered its target to $50.

Varonis Systems Inc (NASDAQ:VRNS) on Tuesday posted better-than-expected earnings for the second quarter.

The company reported quarterly earnings of 4 cents per share which beat the analyst consensus estimate of 1 cent per share. The company reported quarterly sales of $180.023 million which beat the analyst consensus estimate of $176.775 million.

Varonis Systems raised its FY2026 adjusted EPS guidance from $0.11-$0.12 to $0.14-$0.15 and increased its sales guidance from $731.000 million-$737.000 million to $735.000 million-$739.000 million.

Yaki Faitelson, Varonis CEO, said, “Our Q2 results were highlighted by SaaS ARR excluding conversions growth of 25%, SaaS ARR from new logos growing more than 20% and increasing momentum from our newer products, including Atlas, Interceptor, and Database Activity Monitoring. Organizations are prioritizing data and AI security, and we are uniquely positioned to help customers secure sensitive data, govern AI and automate risk reduction.”

Varonis shares fell 8.2% to trade at $41.01 on Wednesday.

These analysts made changes to their price targets on Varonis following earnings announcement.

  • Needham analyst Mike Cikos maintained the stock with a Buy and raised the price target from $40 to $50.
  • Baird analyst Shrenik Kothari maintained the stock with a Neutral and raised the price target from $40 to $45.
  • Barclays analyst Saket Kalia maintained the stock with an Overweight rating and lowered the price target from $52 to $50.
  • TD Cowen analyst Shaul Eyal maintained the stock with a Buy and raised the price target from $50 to $53.

Considering buying VRNS stock? Here’s what analysts think:

Photo via Shutterstock

Login to unlock1,204characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Varonics

Varonics

USVRNS

-0.84%

Barclays

Barclays

USBCS

Barclays

Barclays

UKBARC